المؤلفون: Pérez Rodon, Jordi

المساهمون: University/Department: Universitat Autònoma de Barcelona. Departament de Medicina

مرشدي الرسالة: Galve Basilio, Enrique, Moya Mitjans, Àngel, García-Dorado García, David

المصدر: TDX (Tesis Doctorals en Xarxa)

مصطلحات موضوعية: Tractament farmacològic, Tratamiento farmacológico, Pharmacological treatment, Insuficiència cardíaca, Insuficiencia cardiaca, Heart failure, Desfibril·lador automàtic implantalble, Desfibrilador automático implantable, Implantable cardioverter defibrillator, Ciències de la Salut

وصف الملف: application/pdf

الوصول الحر: http://hdl.handle.net/10803/384242Test

المؤلفون: Lahor i Soler, Eduard

المساهمون: University/Department: Universitat de Barcelona. Departament d'Odontostomatologia

مرشدي الرسالة: Miranda i Rius, Jaume, Sabaté, Xavier, 1950-

المصدر: TDX (Tesis Doctorals en Xarxa)

مصطلحات موضوعية: Marcapassos, Marcapasos cardíacos, Cardiac pacemakers, Interferència electromagnètica, Interferencia electromagnética, Electromagnetic interference, Aparells i instruments odontològics, Material y equipo odontológico, Dental instruments and apparatus, Desfibrilador automático implantable, Desfibril·lador automàtic implantable, Implantable cardioverter-defibrillator, Ciències de la Salut

الوقت: 616.3

وصف الملف: application/pdf

الوصول الحر: http://hdl.handle.net/10803/310945Test

المؤلفون: Luis G. García-Chamorro, Ezequiel J. Zaidel, Lara Gheco, Matías A. Oliva, Alejandro de-la-Vega, Agustín Orosco, Juan Armentano, Álvaro Sosa-Liprandi

المصدر: Archivos de Cardiología de México, Vol 92, Iss 3 (2022)

مصطلحات موضوعية: Desfibrilador automático implantable. Cardiopatía chagásica. Enfermedad de Chagas. Cardiopatía isquémica. Muerte súbita., Diseases of the circulatory (Cardiovascular) system, RC666-701

وصف الملف: electronic resource

العلاقة: https://www.archivoscardiologia.com/frame_esp.php?id=416Test; https://doaj.org/toc/1405-9940Test; https://doaj.org/toc/1665-1731Test

الوصول الحر: https://doaj.org/article/b7055830a4034a03b1995fa00f57e517Test

المؤلفون: García-Chamorro,Luis G., Zaidel,Ezequiel J., Gheco,Lara, Oliva,Matías A., Vega,Alejandro de la, Orosco,Agustín, Armentano,Juan, Sosa-Liprandi,Álvaro

المصدر: Archivos de cardiología de México v.92 n.3 2022

مصطلحات موضوعية: Desfibrilador automático implantable, Cardiopatía chagásica, Enfermedad de Chagas, Cardiopatía isquémica, Muerte súbita

وصف الملف: text/html

الإتاحة: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1405-99402022000300342Test

المؤلفون: Matesanz De La Calle, Andrés

مصطلحات موضوعية: Tratamiento digital de imagen, Morfología matemática, Desfibrilador automático implantable, Arritmias

العلاقة: https://hdl.handle.net/10115/31159Test

الإتاحة: https://hdl.handle.net/10115/31159Test

المؤلفون: Montero Ruiz, Santiago

المساهمون: Rodríguez Vega, Beatriz, Peinado Peinado, Rafael, UAM. Departamento de Psiquiatría, Hospital Universitario La Paz

مصطلحات موضوعية: Ansiedad, Calidad de vida, Desfibrilador automático implantable, Medicina

وصف الملف: application/pdf

العلاقة: http://hdl.handle.net/10486/712270Test

الإتاحة: http://hdl.handle.net/10486/712270Test

المؤلفون: Jesús Castro Hevia, Osmín Castañeda Chirino, Frank Martínez López, Roylán Falcón Rodríguez, Margarita Dorantes Sánchez, Marleny Cruz Cardentey

المصدر: Revista Cubana de Cardiología y Cirugía Cardiovascular, Vol 27, Iss 2, Pp e1106-e1106 (2021)

مصطلحات موضوعية: síndrome de brugada, desfibrilador automático implantable., Internal medicine, RC31-1245, Diseases of the circulatory (Cardiovascular) system, RC666-701

وصف الملف: electronic resource

العلاقة: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/1106Test; https://doaj.org/toc/1561-2937Test

الوصول الحر: https://doaj.org/article/470c25b352c6446bbe0b24bdf27b45d5Test

المؤلفون: Castro Hevia, Jesús, Castañeda Chirino, Osmín, Martínez López, Frank, Falcón Rodríguez, Roylán, Dorantes Sánchez, Margarita, Cruz Cardentey, Marleny

المساهمون: MINSAP

المصدر: Cuban Journal of Cardiology and Cardiovascular Surgery; Vol. 27, No. 2 (2021): Abr-Jun; e1106 ; Revista Cubana de Cardiología y Cirugía Cardiovascular; Vol. 27, No. 2 (2021): Abr-Jun; e1106 ; 1561-2937

مصطلحات موضوعية: Arritmias, Síndrome de Brugada, desfibrilador automático implantable

وصف الملف: application/pdf

العلاقة: https://revcardiologia.sld.cu/index.php/revcardiologia/article/view/1106/1504Test; https://revcardiologia.sld.cu/index.php/revcardiologia/article/downloadSuppFile/1106/896Test; https://revcardiologia.sld.cu/index.php/revcardiologia/article/downloadSuppFile/1106/897Test; 1-Wilde AM, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada R, et al. Proposed diagnostic criteria for the Brugada syndrome. Consensus report. Circulation. 2002;106:2514-9. 2-Sieira J, Brugada P. The definition of the Brugada syndrome. Eur Heart J. 2017;38:3029-3. 3-Lee S, Li KHC, Zhou J, Leung KSK, Lai RWC, Li G, et al. Outcomes in Brugada syndrome patients with implantable cardioverter-defibrillators: Insights from the SGLT2 registry. Front. Physiol. 2020. DOI:10.3389/fphys.2020.00204. 4-Hernandez-Ojeda J, Arbelo E, Borras R, Berne P, Tolosana JM, Gomez-Juanatey A, et al. Patients with Brugada syndrome and implanted cardioverter-defibrillators. Long-term follow-up. Am Coll Cardiol. 2017;70:1991-2002. 5-Pappone C, Brugada J, Vicedomini G, Ciconte G, Manguso F, Saviano M, et al. Electrical substrate elimination in 135 consecutive patients with Brugada syndrome. Circ Arrhythm Electrophysiol. 2017. DOI:10.1161/CIRCEP.117.005053. 6-Belhassen B. Management of Brugada syndrome 2016: should all high risk patients receive an ICD?. Alternatives to implantable cardiac defibrillator therapy for Brugada syndrome. Circ Arrhythm Electrophysiol. 2016. DOI:10.1161/CIRCEP.116. 004185. 7-Sieira J, Brugada P. Management of Brugada syndrome 2016: should all high risk patients receive an ICD?. All high-risk patients should receive an implantable cardiac defibrillator. Circ Arrhythm Electrophysiol. 2016. DOI:10.1161/CIRCEP.116. 004195. 8-Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA/ACC/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. JACC. 2018;72:e91-e220. 9-Antzelevitch C, Yan GX, Ackerman MJ, Borggrefe M, Corrado D, Guo J, et al. J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge. Endorsed by the Asia Pacific Heart Rhythm Society (APHRS), the European Heart Rhythm Association (EHRA), the Heart Rhythm Society (HRS), and the Latin American Society of Cardiac Pacing and Electrophysiology (Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiología [SOLAECE]). Europace. 2017;19:665-9. 10-Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, et al. Brugada syndrome. Report of the second consensus conference. Circulation. 2005;111:659-70. 11-Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Giordano H, et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation. 2002;105:1342-7. 12-Brugada J, Brugada R, Antzelevitch C, Towbin J, Nademanee K, Brugada P. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle branch block and ST-segment elevation in precordial leads V1 to V3. Circulation. 2002;105:73-8. 13-Eckardt L, Probst V, Smits JPP, Schulze E, Wolpert C, Schimpf R, et al. Long-term prognosis of individuals with right precordial ST-segment elevation Brugada syndrome. Circulation. 2005;111:257-63. 14-Probst V, Veltmann C, Eckardt L, Meregalli PG, Gaita F, Tan HL, et al. Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada syndrome registry. Circulation. 2010;121:635-43. 15-Brugada P, Brugada R, Brugada J, Geelen P. Use of the prophylactic implantable cardioverter defibrillator for patients with normal hearts. Am J Cardiol. 1999;83:98D-100D. 16-Brugada P, Brugada R, Brugada J. Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation. 2005;112:279-92. 17-Priori SG, Napolitano C. Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation. 2005;112:279-92. 18-Sacher F, Probst V, Iesaka Y, Jacon P, Laborderie J, Mizon-Gérard F, et al. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: A multicenter study. Circulation. 2006;114:2317-24. 19-Sarkozy A, Boussy T, Kourgiannides G, Chierchia GB, Richter S, De Potter T, et al. Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome. Eur Heart J. 2007;28:334-44. 20-Kharazi A, Emkanjoo Z, Alizadeh A, Nikoo M H, Jorat M V, SadrAmeli MA. Mid-term follow-up of patients with Brugada syndrome following a cardioverter defibrillator implantation: a single center experience. Indian Pacing Electrophysiol J. 2007;7:33-9. 21-Rosso R, Glick A, Glikson M, Wagshal A, Swissa M, Rosenhek S, et al. Outcome after implantation of cardioverter defribrillator in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU). Isr Med Assoc J. 2008;10:435-9. 22-Sacher F, Probst V, Maury P, Mansourati J, Komatsu Y, Marquie C et al. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study–part 2. Circulation 2013;128:1739-47. 23-Miyazaki S, Uchiyama T, Komatsu Y, Taniguchi H, Kusa S, Nakamura H, et al. Long-term complications of implantable defibrillator therapy in Brugada syndrome. Am J Cardiol. 2013;111:1448-51. 24-Conte G, Sieira J, Ciconte G, de Asmundis C, Chierchia GB, Baltogiannis G et al. Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience. J Am Coll Cardiol. 2015;65:879-88. 25-Bordachar P, Reuter S, Garrigue S, Cai X, Hocini M, Jais P, et al. Incidence, clinical implications and prognosis of atrial arrhythmias in Brugada syndrome. Eur Heart J. 2004;25:879-84. 26-Dereci A, Yap SC, Schinkel AFL. Meta-analysis of clinical outcome after implantable cardioverter-defibrillator implantation in patients with Brugada syndrome. J Am Coll Cardiol. 2019;5:141-8. 27-El-Battrawy I, Roterberg G, Liebe V, Ansari U, Lang S, Zhou X, et al. Implantable cardioverter-defibrillator in Brugada syndrome: long-term follow-up. Clinical Cardiology. 2019;42:958-65. 28-Olde Nordkamp LRA, Postema PG, Knops RE, Van Dijk N, Limpens J, Wilde AM, et al. Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications. Heart Rhythm. 2016;13:443-54. 29-Stix G, Della Bella P, Carbucicchio C, Schmidinger H. Spatial and temporal heterogeneity of depolarization and repolarization may complicate implantable cardioverter defibrillator therapy in Brugada syndrome. J Cardiovasc Electrophysiol. 2000;11:516-21. 30-Rodriguez-Mañero M, De Asmundis C, Sacher F, Arbelo E, Probst V, Castro-Hevia J, et al. T-wave oversensing in patients with Brugada syndrome: true bipolar versus integrated bipolar implantable cardioverter defibrillator leads: multicenter retrospective study. Circ Arrhythm Electrophysiol. 2015;8:792-8. 31-Veltmann C, Kuschyk J, Schimpf R, Streitner F, Schoene N, Borggrefe M, et al. Prevention of inappropriate ICD shocks in patients with Brugada syndrome. Clin Res Cardiol. 2010;99:37-44. 32-Spragg DD, Berger RD. How to avoid inappropriate shocks. Heart Rhythm. 2008;5:762-5. 33-Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;367:2275-83. 34-Alter P, Waldhans S, Plachta E, Moosdorf R, Grim W. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. PACE. 2005;28:926-32. 35-Kirkfeldt RE, Johansen JB, Nohr EA, Jorgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2014;35:1186-94. 36-Ranasinghe I, Parzynski CS, Freeman JV, Dreyer RP, Ross JS, Akar JG, et al. Long-term risk for device-related complications and reoperations after implantable cardioverter defibrillator implantation: an observational cohort study. Ann Int Med. 2016;165:20-9. 37-Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of 10 years. Circulation 2007;115:2474-80. 38-Bonny A, Talle MA, Vaugrenard T, Taieb J, Ngantcha M. Inappropriate implantable cardioverter-defibrillator shocks in Brugada syndrome: pattern in primary and secondary prevention. Indian Pacing Electrophysiol J. 2017;17:10-5. 39-Steven D, Roberts-Thomson KC, Inada K, Seiler J, Koplan BA, Tedrow UB, et al. Long-term follow-up in patients with presumptive Brugada syndrome treated with implanted defibrillators. J Cardiovasc Electrophysiol. 2011;22:1115-9. 40-Daoulah A, Alsheikh-Ali AA, Ocheltree AH, Al Fagih AR, Al-Samadi FM, Almusaad AM, et al. Outcome after implantable cardioverter defibrillator in patients with Brugada syndrome: the Gulf Brugada Syndrome registry. J Electrocardiol. 2012;45:327-32. 41-Abud AM, Carlessi A, Goyeneche R, Strada B, Arceluz M, Fernandez A, et al. Retrospective analysis of patients with Brugada syndrome and implantable cardioverter defibrillator. Rev Argent Cardiol. 2014;82:21-5. 42-Makarawate P, Chaosuwannakit N, Vannaprasaht S, Tassaneeyakul W, Sawanyawisuth K. Clinical characteristics and treatment outcomes of patients with Brugada syndrome in Northeastern Thailand. Singapore Med J. 2014;55:217-20. 43-Conte G, Sieira J, Ciconte G, de Asmundis C, Chierchia GB, Baltogiannis G, et al. Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience. J Am Coll Cardiol. 2015;65:879-88. 44-Schukro C, Berger T, Stix G, Pezawas T, Kastner J, Hintringer F, et al. Regional prevalence and clinical benefit of implantable cardioverter defibrillators in Brugada syndrome. Int J Cardiol. 2010;144:191-4. 45-Son MK, Byeon K, Park S-J, Kim JS, Nam JB, Choi KJ, et al. Prognosis after implantation of cardioverter-defibrillators in Korean patients with Brugada syndrome. Yonsei Med J. 2014;55:37-45. 46-Asada S, Morita H, Watanabe A, Nakagawa K, Nagase S, Miyamoto M, et al. Indication and prognostic significance of programmed ventricular stimulation in asymptomatic patients with Brugada syndrome. Europace. 2020. DOI:10.1093/europace/euaa003. 47-Sroubek J, Probst V, Mazzanti A, Delise P, Castro Hevia J, Ohkubo K, et al. Programmed ventricular stimulation for risk stratification in the Brugada syndrome. A pooled analysis. Circulation. 2016;133:622-630 48-Paul M, Gerss J, Schulze-Bahr E, Wichter T, Vahlhaus C, Wilde A, et al. Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data. Eur Heart J. 2007;28:2126-33. 49-Castro Hevia J. ¿Se deben implantar desfibriladores automáticos en pacientes portadores del síndrome de Brugada que hayan presentado síncope de dudosa causa arrítmica o estén asintomáticos?. Rev Cubana Cardiol Cir Cardiovasc. 2010;16:424-30.; https://revcardiologia.sld.cu/index.php/revcardiologia/article/view/1106Test

الإتاحة: https://doi.org/10.3389/fphys.2020.00204Test
https://revcardiologia.sld.cu/index.php/revcardiologia/article/view/1106Test

المؤلفون: Lazo-Soldevilla, Marco, Meza-Centeno, Lizeth

المصدر: Revista de la Sociedad Peruana de Medicina Interna; Vol. 34 Núm. 1 (2021); 31-35 ; Revista de la Sociedad Peruana de Medicina Interna; Vol. 34 No. 1 (2021); 31-35 ; 1609-7173 ; 1681-9721 ; 10.36393/spmi.v34i1

مصطلحات موضوعية: miocardiopatía hipertrófica, muerte súbita cardíaca, desfibrilador automático implantable, hypertrophic cardiomyopathy, sudden cardiac death, implantable cardioverter-defibrillator

وصف الملف: application/pdf

العلاقة: https://revistamedicinainterna.net/index.php/spmi/article/view/582/653Test; https://revistamedicinainterna.net/index.php/spmi/article/view/582Test

الإتاحة: https://doi.org/10.36393/spmi.v34i1.58210.36393/spmi.v34i1Test
https://revistamedicinainterna.net/index.php/spmi/article/view/582Test

المؤلفون: Lazo-Soldevilla, Marco, Meza-Centeno, Lizeth

المصدر: Revista de la Sociedad Peruana de Medicina Interna; Vol. 34 Núm. 1 (2021); 31-35 ; Revista de la Sociedad Peruana de Medicina Interna; Vol 34 No 1 (2021); 31-35 ; 1609-7173 ; 1681-9721 ; 10.36393/spmi.v34i1

مصطلحات موضوعية: hypertrophic cardiomyopathy, sudden cardiac death, implantable cardioverter-defibrillator, miocardiopatía hipertrófica, muerte súbita cardíaca, desfibrilador automático implantable

وصف الملف: application/pdf

العلاقة: https://revistamedicinainterna.net/index.php/spmi/article/view/582/653Test; https://revistamedicinainterna.net/index.php/spmi/article/view/582Test

الإتاحة: https://doi.org/10.36393/spmi.v34i1.582Test
https://doi.org/10.36393/spmi.v34i1Test
https://revistamedicinainterna.net/index.php/spmi/article/view/582Test